To confirm the clinical relevance of our findings, we performed analysis of scRNA-Seq data of tumors from patients with GBM (37), showing that GPNMB was preferentially expressed in classical monocytes, macrophages, and microglia (Figure 7, A and B, and Supplemental Figure 5A). This evidence concerns the gene GPNMB and glioblastoma.